Catalyst Wire Dossier Catalyst Wire Dossier

Sexelaxin

· Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sexelaxin, covering 2019-08-02 to 2019-08-02. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy, Safety and Tolerability of Sexelaxin When Added to Standard Therapy in AHF [Phase 3]

See pricing